EUVIMEDEUVIMED entdecken
Crossref

Improved metabolic stability in iNOS knockout mice with Lactobacillus supplementation

Hobby Aggarwal, Jyoti Gautam, Sonu Kumar Gupta, Bhabatosh Das, Yashwant Kumar, Kumaravelu Jagavelu, Madhu Dikshit

Nutrition Research · 2024

DOI: 10.1016/j.nutres.2024.09.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition Research, 2024. Verfasst von Hobby Aggarwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh 226031, India; Non-communicable Diseases Division, Translational …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Nitric Oxide Synthase Type II, Mice, Knockout, Lactobacillus. Die Arbeit nennt 83 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Biotechnology, Science and Engineering Research Board, Central Drug Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative and nitrosative stress play pivotal roles in normal physiological processes and the pathogenesis of metabolic disorders. Previous studies from our lab demonstrated insulin resistance (IR), and dyslipidemia in iNOS-/- mice, emphasizing the importance of maintaining optimal redox balance. These mice exhibited altered gut microbiota with decreased Lactobacillus. Therefore, we hypothesized that Lactobacillus supplementation could mitigate metabolic disturbances in iNOS-/- mice. To test this hypothesis, iNOS-/- mice and wild-type (WT) mice were divided into four groups: iNOS-/- with or without Lactobacillus supplementation, WT with or without Lactobacillus supplementation and glucose tolerance, insulin resistance, gluconeogenesis, lipids, gene expression related to glucose and lipid metabolism (qPCR), fecal gut microbiota (16S rRNA sequencing), and serum and caecum metabolomics (LC-MS) were monitored. IR and dyslipidemic iNOS-/- mice exhibited reduced microbial diversity, diminished presence of Lactobacillus, and altered serum metabolites, indicating metabolic dysregulation. Lactobacillus supplementation in iNOS-/- mice effectively reversed glucose intolerance, IR, dyslipidemia, and associated metabolic irregularities compared to WT. These improvements correlated with changes in gene expression related to fatty acid synthesis in liver and adipose tissue, lipid oxidation in liver, and lipid efflux in intestinal tissue as compared to untreated iNOS-/- mice. Despite the positive effects on metabolic markers, Lactobacillus supplementation did not reduce body weight or rectify disrupted energy balance, as evidenced by reduced VCO2 production, heat generation, and metabolic rates in iNOS-/- mice. The results suggest that Lactobacillus supplementation ameliorates metabolic disturbances but did not fully restore disrupted energy balance, highlighting complex interactions between the gut microbiome and metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNitric Oxide Synthase Type IIMice, KnockoutLactobacillusInsulin ResistanceDyslipidemiasLipid MetabolismDietary SupplementsAnimalsMiceMaleProbioticsGlucose IntoleranceLiverCecumMice, Inbred C57BLGluconeogenesisFeces

Stichwörter der Autor:innen

DyslipidemiaInsulin resistanceLactobacillusMetabolome analysisObesityiNOS(−/−) mice

Substanzen

Nitric Oxide Synthase Type IINos2 protein, mouse

Autor:innen und Institutionen

  • Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh 226031, India; Non-communicable Diseases Division, Translational Health Science and Technology Institute, Faridabad, Haryana 121001, In…
  • Non-communicable Diseases Division, Translational Health Science and Technology Institute, Faridabad, Haryana 121001, India; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi 110029,…
  • Non-communicable Diseases Division, Translational Health Science and Technology Institute, Faridabad, Haryana 121001, India.
  • Molecular Genetics Laboratory, Infection and Immunology Division, Translational Health Science and Technology Institute, Faridabad, Haryana 121001, India.
  • Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh 226031, India.

Förderung

  • India Ministry of Science & Technology Department of Biotechnology
  • Science and Engineering Research Board
  • Central Drug Research Institute
  • Government of India Ministry of Ayush

Zitieren

APA

Aggarwal, H., Gautam, J., Gupta, S. K., Das, B., Kumar, Y., Jagavelu, K., & Dikshit, M. (2024). Improved metabolic stability in iNOS knockout mice with Lactobacillus supplementation. Nutrition Research. https://doi.org/10.1016/j.nutres.2024.09.018

Vancouver

Aggarwal H, Gautam J, Gupta SK, Das B, Kumar Y, Jagavelu K, et al. Improved metabolic stability in iNOS knockout mice with Lactobacillus supplementation. Nutrition Research. 2024. doi:10.1016/j.nutres.2024.09.018

BibTeX
@article{Aggarwal2024,
  author = {Aggarwal, Hobby and Gautam, Jyoti and Gupta, Sonu Kumar and Das, Bhabatosh and Kumar, Yashwant and Jagavelu, Kumaravelu and Dikshit, Madhu},
  title = {Improved metabolic stability in iNOS knockout mice with Lactobacillus supplementation},
  journal = {Nutrition Research},
  year = {2024},
  doi = {10.1016/j.nutres.2024.09.018}
}
Kostenlos starten →